LivGemini Highlights AI-Powered Cardiovascular Digital Twin Technology

By HospiMedica International staff writers
Posted on 17 Nov 2026

LivGemini (Viterbo, Italy) is showcasing its artificial intelligence (AI)-powered cardiovascular imaging and digital twin technology at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. At Hall 17, Stand B45, the company is highlighting VenusX, its software platform for analyzing thoracic aortic aneurysms from computed tomography (CT) scans. The technology combines AI-based image analysis with patient-specific computational modeling to support cardiovascular research and the development of tools for procedural planning and clinical decision-making.

VenusX is designed for radiologists, cardiologists, and cardiac and vascular surgeons involved in assessing thoracic aortic anatomy. Its Sizing module uses AI algorithms to automatically segment the aorta, identify its centerline, and generate anatomical measurements, including vessel diameters, lengths, volumes, and tortuosity. Users can review and adjust results through linked two-dimensional views and three-dimensional reconstructions before generating structured PDF reports containing measurements, images, and observations.


Image: At Hall 17, Stand B45, the company is highlighting VenusX, its software platform for analyzing thoracic aortic aneurysms from computed tomography (CT) scans. (Photo courtesy of LivGemini)

The platform uses LivGemini's digital twin technology, combining machine learning with physics-based simulations to create patient-specific computational models from medical images. AI algorithms reconstruct anatomical structures into three-dimensional models, while computational methods simulate blood flow, pressure distribution, and mechanical forces using patient-specific anatomy and physiological inputs that may be user-defined or assumed. AI-based reduced-order modeling techniques help accelerate complex simulations, potentially enabling their use on standard workstations.

LivGemini is also developing VenusX Flow, a module that uses patient-specific aortic geometry to estimate hemodynamic parameters, including blood flow velocity, pressure, and wall shear stress. The module combines reconstructed anatomy with physiological inputs to model blood flow behavior. The company's broader research activities also include aneurysm progression, cardiovascular device evaluation, procedural planning, and virtual patient populations for in-silico testing.

VenusX operates as a desktop application for Windows and macOS, processing imaging data locally without transferring patient scans to external servers. Available for research evaluation through agreements with clinical and academic institutions, the software is not CE marked or FDA cleared for clinical use, while VenusX Flow remains under development. Through its participation at MEDICA 2026, LivGemini is highlighting the potential of AI-driven imaging analysis and digital twin modeling to advance cardiovascular research and personalized medical technology.


Latest Medica 2026 News